Find clinical trials for Lung Cancer in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Rochester, MN, USA:
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Rochester, Minnesota, United States and 84 other locations
in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung...
Phase 1, Phase 2
Rochester, Minnesota, United States and 58 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...
Phase 3
Rochester, Minnesota, United States and 294 other locations
and antitumor activity of silevertinib (BDTX-1535). The study population comprises adults with either advanced/metastatic non-small cell lung...
Phase 1, Phase 2
Rochester, Minnesota, United States and 43 other locations
combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small cell lung ...
Phase 1
Rochester, Minnesota, United States and 71 other locations
metastatic pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), HR+/HER2- ductal and lobular breast cancer...
Phase 1
Rochester, Minnesota, United States and 19 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small Cell Lung...
Phase 1, Phase 2
Rochester, Minnesota, United States and 7 other locations
The primary objective of this study is to compare the efficacy of tarlatamab plus durvalumab with durvalumab alone on prolonging overall survival (OS...
Phase 3
Rochester, Minnesota, United States and 223 other locations
The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in...
Phase 1, Phase 2
Rochester, Minnesota, United States and 88 other locations
the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated NSCLC tumors...
Phase 2
Rochester, Minnesota, United States and 37 other locations
Clinical trials
Research sites
Resources
Legal